Product
ZW49
1 clinical trial
1 indication
Indication
HER2-expressing CancersClinical trial
A Phase 1 Study of ZW49 in Patients With Locally Advanced (Unresectable) or Metastatic HER2-Expressing CancersStatus: Active (not recruiting), Estimated PCD: 2025-08-01